Citizens raises Haemonetics price target to $144
Bullish analyst signal; the target remains an opinion and does not establish a change in fundamentals.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish analyst signal; the target remains an opinion and does not establish a change in fundamentals.
What happened, with direct paths to the underlying reporting
Citizens raised its HAE price target to $144 versus the posted price of $122.94, indicating about 17% implied upside.
Target: $144
Posted price: $122.94
Analyst firm: Citizens
Analyst: David Turkaly
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.